Logo
jayshree gosavi @go_667d22ba0b8e4
Vaccines Market Worth $90.52 Billion by 2032
Washington, DC, United States: Vantage Market Research has recently added a new report on Vaccines Market Report History and Forecast 2024-2032, Breakdown Data by Size, Share, Trends, Manufacturers, Challenges, Key Regions, Types and Application.

According to Vantage Market Research, the Global Vaccines Market is estimated to be valued at USD 90.52 Billion by 2030 at an exponential growth rate of 9.5% in the next seven years.

The global Vaccines Market is poised for unprecedented growth, with projections indicating substantial expansion by 2032. A comprehensive research report, "Global Vaccines Market Research Report 2024," delves into the factors driving this surge and offers invaluable insights into this vital industry.

Key Players Mentioned in the Global Vaccines Market Research Report: GlaxoSmithKline plc (UK), Merck & Co., Inc. (US), Pfizer Inc. (US), Sanofi SA (France), CSL Limited (Australia), Emergent BioSolutions Inc. (US), Johnson & Johnson (US), AstraZeneca plc (UK), Serum Institute of India Pvt. Ltd. (India), Bavarian Nordic A/S (Denmark), Mitsubishi Tanabe Pharma Corporation (Japan), Daiichi Sankyo Company, Limited (Japan), Panacea Biotec, Ltd. (India), Biological E Limited (India), Bharat Biotech Ltd. (India), Novavax Inc. (US), FSUE NPO Microgen (Russia), Sinovac Biotech, Ltd. (China), Incepta Vaccine Limited (Bangladesh), Valneva SE (France), VBI Vaccines (US), PT Bio Farma (Persero) (Indonesia), Inovio Ph
5 months ago

No replys yet!

It seems that this publication does not yet have any comments. In order to respond to this publication from jayshree gosavi, click on at the bottom under it